11 Result(s)

Article

Optimising Radioligand Therapy for Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumours: Expert Opinion from an Italian Multidisciplinary Group

Radioligand therapy (RLT) with lutetium (¹⁷⁷Lu) oxodotreotide is an approved therapy in combination with somatostatin analogues (SSAs) for patients with advanced, well-differentiated G1–G2, gastro-entero-pancreat...

Nicola Fazio, Massimo Falconi, Emanuela Foglia, Mirco Bartolomei… in Advances in Therapy (2024)

Article

Terapia del carcinoma corticosurrenalico dopo fallimento del mitotane

Il mitotane rappresenta l’unico farmaco approvato con specifica attività citotossica sulle cellule della corticale del surrene. Viene utilizzato nella terapia medica del carcinoma corticosurrenalico (ACC) nel ...

Salvatore Grisanti, Valentina Cremaschi, Alfredo Berruti in L'Endocrinologo (2023)

Article

Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question

Whether or not androgen receptor (AR) axis could still be targetable in castration resistant prostate cancer (CRPC) patients with disease progression to next generation hormonal agents (NGHAs) is a controversi...

Irene Caramella, Alberto Dalla Volta, Marco Bergamini, Deborah Cosentini… in Endocrine (2022)

Article

Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen

The management of patients with advanced/metastatic adrenocortical carcinoma (ACC) is challenging, EDP-M (etoposide, doxorubicin, cisplatin combined with mitotane) is the standard regimen. However, it is quite...

Antonella Turla, Marta Laganà, Salvatore Grisanti, Andrea Abate… in Endocrine (2022)

Article

Eighth International Adrenal Cancer Symposium Brescia, Italy, September 30 to October 1–2, 2021

Alfredo Berruti, Massimo Terzolo, Sebastiano Filetti in Endocrine (2022)

Article

FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma

FGF/FGFR signaling regulates embryogenesis, angiogenesis, tissue homeostasis and wound repair by modulating proliferation, differentiation, survival, migration and metabolism of target cells. Understandably, c...

Mariangela Tamburello, Barbara Altieri, Iuliu Sbiera, Sandra Sigala… in Endocrine (2022)

Article

Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines?

Pediatric and adult adrenocortical carcinomas differ in many respects but treatment is often similar in both age groups. The Journal of Clinical Oncology recently published the results of a risk-stratified single...

Salvatore Grisanti, Deborah Cosentini, Marta Laganà, Antonella Turla… in Endocrine (2021)

Article

Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy

Deborah Cosentini, Salvatore Grisanti, Marta Laganà, Vittorio Domenico Ferrari… in Endocrine (2021)

Article

Maintenance everolimus beyond progression in pancreatic NET to control insulinoma syndrome

Valeria Tovazzi, Vittorio D. Ferrari, Alfredo Berruti in Endocrine (2021)

Article

5th International ACC Symposium: Future and Current Therapeutic Trials in Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare and complex disease associated with a high mortality rate. Despite intensive translational and clinical research, prognosis remains poor. Over the past decade, a signif...

Ana O. Hoff, Alfredo Berruti in Hormones and Cancer (2016)

Article

Metronomic Therapy Concepts in the Management of Adrenocortical Carcinoma

Metronomic chemotherapy is the administration of cytotoxic drugs at low doses, on a frequent or continuous schedule, with no extended interruption. This treatment approach can target tumor cells indirectly sin...

Alfredo Berruti, Paola Sperone, Elisa Bellini, Fulvia Daffara… in Hormones and Cancer (2011)